Cumulative social disadvantage and health-related quality of life: national health interview survey 2013-2017.
Kobina HaganZulqarnain JavedMiguel Cainzos-AchiricaAdnan A HyderElias MossialosTamer YahyaIsaac AcquahJavier Valero-ElizondoAlan PanNwabunie NwanaMohamad TahaKhurram NasirPublished in: BMC public health (2023)
Cumulative social disadvantage was associated with poorer HALex performance in an incremental fashion. Innovations to incorporate SDoH-screening tools into clinical decision systems must continue in order to accurately identify socially vulnerable groups in need of both clinical risk mitigation and social support. To maximize health returns, policies can be tailored through community partnerships to address systemic barriers that exist within distinct sociodemographic groups, as well as demographic differences in health perception and healthcare experience.